Prenatal Exposure to Phentermine-Topiramate Lower Under Safety Program
TUESDAY, March 21, 2023 -- Under the Risk Evaluation and Mitigation Strategy (REMS), prenatal exposure to phentermine-topiramate is lower than topiramate and other antiobesity medications (AOMs), according to a study published online March 21 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2023 Category: Pharmaceuticals Source Type: news
Ozempic Back on Shelves; More Positive Fezolinetant Data; Caffeine Cuts Fat?
(MedPage Today) -- After major shortages of semaglutide (Ozempic), the 0.25 mg, 0.5 mg, and 1 mg doses are back on shelves. The 2 mg dose still has limited availability until the end of March. (Reuters)
Prenatal exposure to phentermine-topiramate... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - March 21, 2023 Category: Endocrinology Source Type: news
Recommending Exercise for Migraine: Just Do It Recommending Exercise for Migraine: Just Do It
Strength training is the most effective form of exercise for reducing migraine, with high-intensity aerobics coming in second, but both beat top-line migraine meds topiramate and amitriptyline, new research suggests.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - November 22, 2022 Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news
U.K. Health Authority Investigates Epilepsy Drug's Link to Autism
The Medicines and Healthcare products Regulatory Agency's investigation comes after a study showed prenatal exposure to topiramate roughly triples a child's likelihood of having autism or intellectual disability. (Source: The Scientist)
Source: The Scientist - August 30, 2022 Category: Science Tags: News & Opinion Source Type: news
FDA Expands Use of Weight-Loss Drug to Adolescents
(MedPage Today) -- The FDA approved a supplemental indication for phentermine/topiramate extended-release capsules (Qsymia) for chronic weight management in adolescents ages 12 and older with obesity, defined as a body mass index (BMI) in the 95th... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 28, 2022 Category: American Health Source Type: news
FDA approves treatment for chronic weight management in pediatric patients aged 12 years and older
The U.S. Food and Drug Administration has approved a supplemental indication for Qsymia (phentermine and topiramate extended-release capsules) for chronic weight management in pediatric patients aged 12 years and older who are obese, defined as a body mass index (BMI) of 95th percentile or greater w (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 27, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA Approves Qsymia for Chronic Weight Management in Certain Pediatric Patients Aged 12 years and Older
June 27, 2022 -- The U.S. Food and Drug Administration has approved a supplemental indication for Qsymia (phentermine and topiramate extended-release capsules) for chronic weight management in pediatric patients aged 12 years and older who are... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 27, 2022 Category: Drugs & Pharmacology Source Type: news
Prenatal Exposure to Certain Antiseizure Meds Linked to Autism
Risks for ASD, intellectual disability may be increased with prenatal exposure to topiramate, valproate, certain duotherapies (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - May 31, 2022 Category: Psychiatry Tags: Family Medicine, Gynecology, Neurology, Pediatrics, Pharmacy, Psychiatry, Journal, Source Type: news
Prenatal Exposure to Certain Antiseizure Meds Linked to Autism
TUESDAY, May 31, 2022 -- Prenatal exposure to topiramate, valproate, and certain duotherapies is associated with increased risks for autism spectrum disorder (ASD) and intellectual disability (ID), according to a study published online May 31 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 31, 2022 Category: Pharmaceuticals Source Type: news
Erenumab Bests Topiramate in First Head-to-Head Migraine Trial Erenumab Bests Topiramate in First Head-to-Head Migraine Trial
The calcitonin-gene related peptide receptor inhibitor erenumab is more effective and tolerable than topiramate for treating migraine, new research suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - November 19, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Eprontia (Topiramate Oral Solution) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 17, 2021 Category: Drugs & Pharmacology Source Type: news
Is Phentermine/Topiramate Helpful After Teen Bariatric Surgery? Is Phentermine/Topiramate Helpful After Teen Bariatric Surgery?
' We do not yet know what the optimal dose or postoperative timing of phentermine/topiramate (or any other anti-obesity medication) is after bariatric surgery in adolescents, ' says the author of a pilot study.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 15, 2021 Category: Cardiology Tags: General Surgery News Source Type: news
FDA Approves Eprontia (topiramate) Oral Solution for Epilepsy and Preventive Treatment of Migraine
WOBURN, MA, November 8, 2021– Azurity Pharmaceuticals, Inc. a private specialty pharmaceutical company focused on developing innovative products to meet the unique needs of patients with underserved conditions, today announced the U.S. Food... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 8, 2021 Category: Drugs & Pharmacology Source Type: news
AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF EPRONTIA(TM) (topiramate) oral solution
The first and only FDA-approved ready-to-use liquid topiramate
WOBURN, Mass., Nov. 8, 2021 -- (Healthcare Sales & Marketing Network) -- Azurity Pharmaceuticals, Inc. a private specialty pharmaceutical company focused on developing innovative products t... Biopharmaceuticals, Neurology, FDA Azurity Pharmaceuticals, EPRONTIA , topiramate, Lennox-Gastaut syndrome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 8, 2021 Category: Pharmaceuticals Source Type: news
topiramate
Title: topiramateCategory: MedicationsCreated: 9/11/2002 12:00:00 AMLast Editorial Review: 10/13/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 13, 2021 Category: Drugs & Pharmacology Source Type: news
